Hernán MA - Search Results

1

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.

HIV-CAUSAL Collaboration; Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA. HIV-CAUSAL Collaboration, et al. Among authors: hernan ma. Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6. Clin Infect Dis. 2015. PMID: 25567330 Free PMC article.

2

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.

Choi HK, Hernán MA, Seeger JD, Robins JM, Wolfe F. Choi HK, et al. Among authors: hernan ma. Lancet. 2002 Apr 6;359(9313):1173-7. doi: 10.1016/S0140-6736(02)08213-2. Lancet. 2002. PMID: 11955534

3

Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures.

Hernán MA, Brumback BA, Robins JM. Hernán MA, et al. Stat Med. 2002 Jun 30;21(12):1689-709. doi: 10.1002/sim.1144. Stat Med. 2002. PMID: 12111906

4

Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models.

Cole SR, Hernán MA, Robins JM, Anastos K, Chmiel J, Detels R, Ervin C, Feldman J, Greenblatt R, Kingsley L, Lai S, Young M, Cohen M, Muñoz A. Cole SR, et al. Among authors: hernan ma. Am J Epidemiol. 2003 Oct 1;158(7):687-94. doi: 10.1093/aje/kwg206. Am J Epidemiol. 2003. PMID: 14507605

5

Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures.

Brumback BA, Hernán MA, Haneuse SJ, Robins JM. Brumback BA, et al. Among authors: hernan ma. Stat Med. 2004 Mar 15;23(5):749-67. doi: 10.1002/sim.1657. Stat Med. 2004. PMID: 14981673

6

A structural approach to selection bias.

Hernán MA, Hernández-Díaz S, Robins JM. Hernán MA, et al. Epidemiology. 2004 Sep;15(5):615-25. doi: 10.1097/01.ede.0000135174.63482.43. Epidemiology. 2004. PMID: 15308962

7

Structural accelerated failure time models for survival analysis in studies with time-varying treatments.

Hernán MA, Cole SR, Margolick J, Cohen M, Robins JM. Hernán MA, et al. Pharmacoepidemiol Drug Saf. 2005 Jul;14(7):477-91. doi: 10.1002/pds.1064. Pharmacoepidemiol Drug Saf. 2005. PMID: 15660442

8

Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.

Sterne JA, Hernán MA, Ledergerber B, Tilling K, Weber R, Sendi P, Rickenbach M, Robins JM, Egger M; Swiss HIV Cohort Study. Sterne JA, et al. Among authors: hernan ma. Lancet. 2005 Jul 30-Aug 5;366(9483):378-84. doi: 10.1016/S0140-6736(05)67022-5. Lancet. 2005. PMID: 16054937

9

Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count.

Cole SR, Hernán MA, Margolick JB, Cohen MH, Robins JM. Cole SR, et al. Among authors: hernan ma. Am J Epidemiol. 2005 Sep 1;162(5):471-8. doi: 10.1093/aje/kwi216. Epub 2005 Aug 2. Am J Epidemiol. 2005. PMID: 16076835

10

Comparison of dynamic treatment regimes via inverse probability weighting.

Hernán MA, Lanoy E, Costagliola D, Robins JM. Hernán MA, et al. Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):237-42. doi: 10.1111/j.1742-7843.2006.pto_329.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16611197 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

375 results

Search Page